-
Relypsa Up 10% Following Encouraging Phase 1 Study Results
Tuesday, January 26, 2016 - 9:30am | 262Read More...Shares of Relypsa Inc (NASDAQ: RLYP), a biopharmaceutical company that focuses on non-absorbed polymeric drugs to tread disorders in the areas of renal, cardiovascular and metabolic diseases, were trading higher by more than 10 percent early Tuesday morning. Relypsa announced after Monday's close...
-
Wedbush Offers Probabilities For Upcoming Catalysts In Emerging Pharmas
Tuesday, December 8, 2015 - 9:29am | 850Read More...Liana Moussatos of Wedbush overviewed the emerging pharmaceuticals space and offered a scenario analysis of various potential catalysts. Moussatos has the highest degree of confidence on two upcoming catalysts for Relypsa Inc (NASDAQ: RLYP), one of which could see its stock move up or down by as...
